What if a cannabis compound could revolutionize the fight against cancer? Discovered in 2023 by a South Korean team, Cannabielsoxa is a rare cannabinoid that is talking about him for his potential against the neuroblastoma, aggressive pediatric cancer. But what makes this compound so promising? In this article, explore its properties, applications and what science says today.
Stay with us to dive into this fascinating advance of medical cannabis And find out how cannabielsoxa could change the situation in France and elsewhere.
Discovery and scientific properties
What can CannabielSOXA?
Cannabielsoxa is a Rare cannabinoid identified in cannabis by a team from the University of Seoul in 2023. thanks to advanced techniques such as the mass spectrometry and the chromatography, the researchers have isolated this compound, revealing a unique chemical structure. Unlike THC, it has no psychoactive effects, making it an ideal candidate for medical applications.
Promising anti -tumor potential
The first studies, published in MDPI, suggest that cannabielsoxa could induce the apoptosis (programmed cell death) of cancer cells in neuroblastoma. It interacts with the CB1 and CB2 receptors of the endocannabinoid system, playing a key role in the regulation of cell signaling routes.
To better understand, imagine cannabielsoxa as a molecular key which selectively deactivates malignant cells without affecting healthy cells. However, clinical studies are necessary to confirm these results.
Did you know? More than 100 different cannabinoids have been identified in cannabis, but only THC and CBD are well known!
Cannabielsoxa vs THC and CBD: the differences
| Criteria |
Cannabielsoxa |
THC |
CBD |
| Psychoactive effect |
No |
Yes |
No |
| Main application |
Neuroblastoma |
Pain, appetite |
Anxiety, inflammation |
| Legal status (France) |
Clarifying |
Forbidden |
Authorized (low THC) |
Discover our complete guide on cannabinoids
Implications and perspectives
Cannabielsoxa in the treatment of neuroblastoma
Neuroblastoma is rare cancer mainly affecting children. Currently, treatments (chemotherapy, radiotherapy) are heavy and not always effective. Cannabielsoxa could offer a targeted alternative, but research is still at a preliminary stage. No human clinical data is available to date.
Towards a new era of medical cannabis in France?
In France, the medical cannabis is authorized in specific cases since 2021. If Cannabielsoa proves its effectiveness, it could integrate therapeutic protocols, subject to regulatory clarifications. Researchers call for in-depth studies to explore its applications beyond neuroblastoma.
FAQ on cannabielsoxa
- What can CannabielSOXA?
- CannabielSOXA is a rare cannabinoid discovered in 2023 by South Korean researchers. It shows an antitumoral potential, especially against neuroblastoma.
- Does cannabielsa have side effects?
- No clinical data indicates side effects for the moment, but additional studies are necessary.
- Is it legal in France?
- The legality of cannabielsoa depends on the regulations on cannabinoids in France. Consult the health authorities for more information.
- How does he compare himself to the CBD?
- Unlike CBD, cannabielsoxa has no known anxiolytic effects, but it specifically targets cancer cells in neuroblastoma.
Conclusion
Cannabielsoxa represents a promising advance in research on the medical cannabis. Although studies are still preliminary, this cannabinoid could open the way for new treatments against neuroblastoma. Stay informed of the latest discoveries and explore the potential of cannabinoids!
To go further, read our article: The benefits of the CBD explained.
Infographic: cannabinoid synthesis cycle
Description : This infographic illustrates how cannabis produces cannabinoids like cannabielsoxa. 1) Chemical precursors (CBGA) are formed in the plant. 2) Enzymes Transform CBGA into cannabielsoxa, THC or CBD. 3) The final compounds are extracted for medical applications.
